Your browser doesn't support javascript.
loading
An analysis of prognostic factors for stage ⅢA (N2) non-small cell lung cancer after complete resection / 中华放射肿瘤学杂志
Article in Zh | WPRIM | ID: wpr-503794
Responsible library: WPRO
ABSTRACT
Objective To investigate the factors associated with postoperative metastasis, recurrence, and survival in patients with stage ⅢA ( N2 ) non?small cell lung cancer ( NSCLC ) , and to provide an objective basis for postoperative radiotherapy in patients. Methods Clinical data were collected from 199 patients who underwent complete resection and were diagnosed with stage ⅢA ( N2 ) NSCLC after surgery in our hospital from 2009 to 2013. The Cox regression model was used for the multivariate analyses of metastasis and recurrence. The survival rates were calculated using the Kaplan?Meier method and analyzed using the log?rank test. Results In the 199 patients, 173 had complete follow?up data. The 1?and 2?year metastasis, recurrence, and survival rates were 38?7%/52?6%, 27?8%/39?1%, and 92?5%/51?4%, respectively. The multivariate analysis showed that pathological type and two positive indices among preoperative CEA/CY211/SCC were two risk factors for metastasis ( P=0?013,0?014) . Positive lymph node number, metastatic lymph node number, lymph node metastasis rate, and two positive indices among preoperative CEA/CY211/SCC were risk factors for recurrence ( P=0?046,0?004,0?028,0?001) . All the above indices were risk factors for low survival rates ( P= 0?013 , 0?011 , 0?002,0?026 ) . Conclusions Patients with stage ⅢA ( N2 ) NSCLC who have positive lymph nodes, lymph node metastases, and two positive indices among preoperative CEA/CY211/SCC may benefit from postoperative radiotherapy.
Key words
Full text: 1 Index: WPRIM Type of study: Prognostic_studies / Risk_factors_studies Language: Zh Journal: Chinese Journal of Radiation Oncology Year: 2016 Type: Article
Full text: 1 Index: WPRIM Type of study: Prognostic_studies / Risk_factors_studies Language: Zh Journal: Chinese Journal of Radiation Oncology Year: 2016 Type: Article